<?xml version="1.0" encoding="UTF-8"?>
<p>Other antiviral treatments for COVID-19 currently undergoing clinical trials include protease inhibitors (nelfinavir, camostat mesilate, ritonavir, danoprevir, darunavir, flavopiridol, relacatib), nucleoside analogues (galidesivir), fusion inhibitors (umifenovir), RNA polymerase inhibitors (favipiravir), and neuraminidase inhibitors (oseltamivir).
 <xref rid="b76-dic-2020-4-15" ref-type="bibr">76</xref>
</p>
